 Merck  Co unveiled an unusual plan to collaborate with three rivalsPfizer Inc Amgen Inc and Incyte Corpto study how Mercks immunotherapy cancer drug performs in combination with other treatments  The partnerships underscore the industrys intensifying competition in immunotherapy drugs which are designed to unleash the patients immune system to fight cancer Merck BristolMyers Squibb Co and Roche Holding Ltd are among the companies developing immunotherapy drugs for what analysts say could be a multibilliondollar
  